High-dose gallium-67 therapy in patients with relapsed acute leukaemia: a feasibility study.

por Jonkhoff, A. R., Plaizier, M. A., Ossenkoppele, G. J., Teule, G. J., Huijgens, P. C.
Publicado 1995

ALK expression in extranodal anaplastic large cell lymphoma favours systemic disease with (primary) nodal involvement and a good prognosis and occurs before dissemination

por Berge, R., Oudejans, J., Ossenkoppele, G., Pulford, K., Willemze, R., Falini, B., Chott, A., Meijer, C.
Publicado 2000

Relation of CD30 expression to survival and morphology in large cell B cell lymphomas.

por Noorduyn, L A, de Bruin, P C, van Heerde, P, van de Sandt, M M, Ossenkoppele, G J, Meijer, C J
Publicado 1994

Gallium-67 radiotoxicity in human U937 lymphoma cells.

por Jonkhoff, A. R., Huijgens, P. C., Versteegh, R. T., van Dieren, E. B., Ossenkoppele, G. J., Martens, H. J., Teule, G. J.
Publicado 1993

Factors that influence treatment decision-making in elderly DLBCL patients: a case vignette study

por van der Poel, M. W. M., Mulder, W. J., Ossenkoppele, G. J., Maartense, E., Hoogendoorn, M., Wijermans, P., Schouten, H. C.
Publicado en Ann Hematol (2015)

Fluconazole versus itraconazole for the prevention of fungal infections in haemato-oncology.

por Huijgens, P C, Simoons-Smit, A M, van Loenen, A C, Prooy, E, van Tinteren, H, Ossenkoppele, G J, Jonkhoff, A R
Publicado 1999

Effects of the ACTH(4-9) analogue, ORG 2766, on vincristine cytotoxicity in two human lymphoma cell lines, U937 and U715.

por Kiburg, B., van de Loosdrecht, A. A., Schweitzer, K. M., Ossenkoppele, G. J., Müller, L. J., Heimans, J. J., Huijgens, P. C.
Publicado 1994

In silico and preclinical drug screening identifies dasatinib as a targeted therapy for T-ALL

por Laukkanen, S, Grönroos, T, Pölönen, P, Kuusanmäki, H, Mehtonen, J, Cloos, J, Ossenkoppele, G, Gjertsen, B, Øystein, B, Heckman, C, Heinäniemi, M, Kontro, M, Lohi, O
Publicado en Blood Cancer J (2017)

Granzyme B expression in Reed-Sternberg cells of Hodgkin's disease.

por Oudejans, J. J., Kummer, J. A., Jiwa, M., van der Valk, P., Ossenkoppele, G. J., Kluin, P. M., Kluin-Nelemans, J. C., Meijer, C. J.
Publicado 1996

Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors

por Thijsen, S F T, Schuurhuis, G J, Oostveen, J W van, Theijsmeijer, A P, van der Hem, K G, Odding, J H, Dräger, A M, Ossenkoppele, G J
Publicado 1999

Plerixafor and granulocyte colony-stimulating factor for first-line steady-state autologous peripheral blood stem cell mobilization in lymphoma and multiple myeloma: results of the...

por Russell, Nigel, Douglas, Kenny, Ho, Anthony D., Mohty, Mohamad, Carlson, Kristina, Ossenkoppele, G.J., Milone, Giuseppe, Pareja, Macarena Ortiz, Shaheen, Daniel, Willemsen, Arnold, Whitaker, Nicky, Chabannon, Christian
Publicado 2013

IGFBP7 induces apoptosis of acute myeloid leukemia cells and synergizes with chemotherapy in suppression of leukemia cell survival

por Verhagen, H JMP, de Leeuw, D C, Roemer, M GM, Denkers, F, Pouwels, W, Rutten, A, Celie, P H, Ossenkoppele, G J, Schuurhuis, G J, Smit, L
Publicado en Cell Death Dis (2014)

A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomas.

por Dukers, D F, ten Berge, R L, Oudejans, J J, Pulford, K, Hayes, D, Miseré, J F, Ossenkoppele, G J, Jaspars, L H, Willemze, R, Meijer, C J
Publicado 1999

Hypermethylation of the FANCC and FANCL Promoter Regions in Sporadic Acute Leukaemia

por Hess, C. J., Ameziane, N., Schuurhuis, G. J., Errami, A., Denkers, F., Kaspers, G. J. L., Cloos, J., Joenje, H., Reinhardt, D., Ossenkoppele, G. J., Zwaan, C. M., Waisfisz, Q.
Publicado en Cell Oncol (2008)

CD40-targeted adenoviral GM-CSF gene transfer enhances and prolongs the maturation of human CML-derived dendritic cells upon cytokine deprivation

por Stam, A G M, Santegoets, S J A M, Westers, T M, Sombroek, C C, Janssen, J J W M, Tillman, B W, Loosdrecht, A A van de, Pinedo, H M, Curiel, D T, Ossenkoppele, G J, Scheper, R J, de Gruijl, T D
Publicado 2003

High-vs low-dose cytarabine combined with interferon alfa in patients with first chronic phase chronic myeloid leukemia. A prospective randomized phase III study

por Deenik, W., van der Holt, B., Verhoef, G. E. G., Schattenberg, A. V. M. B., Verdonck, L. F., Daenen, S. M. G. J., Zachée, P., Westveer, P. H. M., Smit, W. M., Wittebol, S., Schouten, H. C., Löwenberg, B., Ossenkoppele, G. J., Cornelissen, J. J.
Publicado en Ann Hematol (2006)

Frontline nilotinib in patients with chronic myeloid leukemia in chronic phase: results from the European ENEST1st study

por Hochhaus, A, Rosti, G, Cross, N C P, Steegmann, J L, le Coutre, P, Ossenkoppele, G, Petrov, L, Masszi, T, Hellmann, A, Griskevicius, L, Wiktor-Jedrzejczak, W, Rea, D, Coriu, D, Brümmendorf, T H, Porkka, K, Saglio, G, Gastl, G, Müller, M C, Schuld, P, Di Matteo, P, Pellegrino, A, Dezzani, L, Mahon, F-X, Baccarani, M, Giles, F J
Publicado en Leukemia (2016)